Wort "Pharma" umgeben von Symbolen - Herz, Tabletten, Arzt, Ergebnisbogen, Spritze
Our industry-specific expertise:
Pricing & Market Access Strategy

Bespoke end-to-end pricing & market access solutions along the entire product lifecycle

Increasing drug costs in the health care systems are a key issue on the political agenda. The result is growing price pressure on pharmaceutical companies. Optimized price and market access strategies along the entire product life cycle is becoming increasingly important. Homburg & Partner can help you find the suitable pricing and market access strategy for your product – from launch pricing to generics/biosimilar defense in mature markets. We offer customized solutions for all major EU countries as well as the US healthcare market.

Building on a comprehensive market analysis, the price readiness of various market participants is evaluated and translated into price recommendations. Our recommendations are always adapted to the needs of the respective reimbursement sector and the strategic objectives of the product. In order to enforce the identified prices on the market, we will also support you in designing a suitable contract strategy.

Our Pricing & Market Access Framework – the compass to implementing pricing strategies

Darstellung des Product Life Cycle im Market Access Bereich der Pharmaindustrie

The four steps in detail:

Schriftzug Trial Design & Early Access in Textbox
Startende Rakete mit kreisförmigen Linien drumherum
  • Phase-III trial design maximizing EU-5 wide price potential
  • Endpoint selection optimizing payer value perception across EU-5 country
  • Patient subgroup analysis outlining price vs. patient population trade-off
  • Feasibility assessment of potential post-hoc analysis per EU-5 country
Schriftzug International & National Pricing & Reimbursement Strategy in Textbox
Strategiepfad durch Linienfeld mit kreisförmigen Linien drumherum
  • EU-5 pricing strategy incl. price corridors & reimbursement situation
  • Outcome of HTA drug evaluation for each EU-5 country
  • Price sensitivities of payers & prescribing behavior of HCPs
  • Reimbursement hurdles / HCP prescription hurdles per EU-5 country
Schriftzug Local Pricing & Contracting Strategy in Textbox
Kreis mit Pfeilen, die auf umgebende Elemente zeigen mit kreisförmigen Linien drumherum
  • Needed rebate structure on local level on top of list price
  • Sector-specific contracting strategy to implement rebates
  • Sector-specific service offerings to optimize product positioning
  • Needs analysis across stakeholders (HCPs, pharmacists, payer, etc.)
Schriftzug Market Access Lifecycle Tactics in Textbox
Laptop mit Diagramm mit kreisförmigen Linien drumherum
  • Multi-channel disease awareness concept across stakeholders
  • Value communication strategy for local physician associations
  • Access factbook for sales force to address reimbursement questions
  • Local in-field access interaction & visit plan for defined territories

Our pricing & market access fields of expertise for the German market:

Startende Rakete mit kreisförmigen Linien drumherum
Launch Pricing Strategy
  • Sector-specific launch prices for sick funds and hospital pharmacies
  • Market share developments for different launch price scenarios
  • Price sensitivities & prescribing behavior of HCPs
  • Price thresholds that constitute prescribing hurdles
Strategiepfad durch Linienfeld mit kreisförmigen Linien drumherum
AMNOG Pricing Strategy
  • Outcome of G-BA benefit evaluation following §35a SGB V
  • Expected discounts after GKV-SV price negotiations (§130b SGB V)
  • Most likely appropriate comparator therapy for AMNOG process
  • Potential patient sub-group analyses performed by IQWIG / G-BA
Kreis mit Pfeilen, die auf umgebende Elemente zeigen mit kreisförmigen Linien drumherum
Local Pricing & Contracting Strategy
  • Needed rebate structure on regional level on top of AMNOG discounts
  • Sector-specific contract strategy to implement rebates
  • Sector-specific service offerings to optimize product positioning
  • Needs analysis across stakeholders (HCPs, pharmacists, payer, etc.)
Laptop mit Diagramm mit kreisförmigen Linien drumherum
Local Access Lifecycle Tactics
  • Multi-channel disease awareness concept across stakeholders
  • Value communication strategy for sick funds & KVs
  • Access factbook for sales force to address reimbursement questions
  • Local in-field access interaction & visit plan for defined territories

Our experts for the pharmaceutical sector

Porträtbild unseres Partners Christian Zuberer
Partner

Christian Zuberer

christian.zuberer@homburg-partner.com
Tel.: +49 621 1582-212

Porträtbild von Michael Scholl
Managing Director & Partner

Dr. Michael Scholl

michael.scholl@homburg-partner.com
Tel.: +49 621 1582-0